T2DM is a chronic metabolic disorder characterized by a hyperglycemia status resulting primarily from the combination of progressive impairment of insulin secretion by pancreatic islet β-cells and insulin action on target tissues (4,5). The gene discussed is INS; the disease is type 2 diabetes mellitus.